Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BLOKBIS TABLET 2.5MG

Approval Number

SIN15804P

Drug Name

BLOKBIS TABLET 2.5MG

Product Name

BLOKBIS TABLET 2.5MG

Approval Date

September 12, 2019

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

C07AB07

ATC Item Name

bisoprolol

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

Chanelle Medical Unlimited Company

Active Ingredients

Ingredient Name

Bisoprolol Fumarate

Strength

2.5 mg

Drug MonographBisoprolol

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

BLOKBIS TABLET 2.5MG - HSA Approval | MedPath